MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
    • careers
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Skincare
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Medical Marijuana, Inc. Records Best Revenue Quarter in Company History

Medical Marijuana, Inc. Records Best Revenue Quarter in Company History

by adminTorusBrand | May 22, 2019 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, Kannaway

Important achievements from across our portfolio of companies helped drive record revenue and continued success in the opening months of 2019. Medical Marijuana, Inc. and our portfolio of companies and investments continued our upward trend in the first fiscal quarter...
Medical Marijuana, Inc. CEO Invited to Speak at FDA Hearing on Cannabis and CBD

Medical Marijuana, Inc. CEO Invited to Speak at FDA Hearing on Cannabis and CBD

by adminTorusBrand | May 21, 2019 | Company News

Dr. Stuart Titus to be one of 65 cannabis experts to speak on cannabis and CBD at special public hearing to determine how to regulate products containing cannabis and its derivatives. The U.S. Food & Drug Administration will be holding a public hearing to gather...
AXIM® Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment

AXIM® Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment

by adminTorusBrand | May 20, 2019 | Axim Biotechnologies, Company News

Medical Marijuana, Inc. investment AXIM® Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines. Leading cannabinoid research and new drug development company AXIM® Biotechnologies recently filed...
Medical Marijuana, Inc. Adds New Dixie Botanicals CBD Isolate Tincture to Store

Medical Marijuana, Inc. Adds New Dixie Botanicals CBD Isolate Tincture to Store

by adminTorusBrand | May 17, 2019 | Company News, Dixie Botanicals

Our newest product features 99% pure CBD and a sweet citrus flavor for a daily use CBD tincture that everyone in your family can enjoy. We are excited to announce the addition of our brand new CBD Isolate Tincture to the Medical Marijuana, Inc. line of products. Dixie...
HempMeds® Brasil Invites Doctors to U.S. Offices for Educational Symposium

HempMeds® Brasil Invites Doctors to U.S. Offices for Educational Symposium

by adminTorusBrand | May 10, 2019 | Company News, HempMeds Brasil

The first company to legally ship CBD products to Brazil, subsidiary HempMeds® Brasil continues its series of educational CBD symposiums for doctors with event in hometown. Medical Marijuana, Inc. subsidiary HempMeds® Brasil hosted an International Symposium on...
Kannaway Redefines Brand at Successful Believe National Convention

Kannaway Redefines Brand at Successful Believe National Convention

by adminTorusBrand | May 6, 2019 | Company News, Kannaway

Medical Marijuana, Inc. subsidiary Kannaway, introduces new products, new branding and marketing, new incentives, and more at recent annual event. During the weekend of April 13th & 14th, Kannaway invited its team of brand ambassadors to its hometown of San Diego...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.